IVZ vs. BEN: Which Stock Should Value Investors Buy Now? — Positive
BEN IVZ Zacks Investment Research — July 14, 2025Investors interested in Financial - Investment Management stocks are likely familiar with Invesco (IVZ) and Franklin Resources (BEN). But which of these two stocks presents investors with the better value opportunity right now?

VIRT vs. MCO: Which Stock Is the Better Value Option? — Positive
MCO VIRT Zacks Investment Research — July 14, 2025Investors with an interest in Financial - Miscellaneous Services stocks have likely encountered both Virtu Financial (VIRT) and Moody's (MCO). But which of these two stocks is more attractive to value investors?

VWDRY vs. ETN: Which Stock Should Value Investors Buy Now? — Positive
ETN VWDRY Zacks Investment Research — July 14, 2025Investors interested in Manufacturing - Electronics stocks are likely familiar with Vestas Wind Systems AS (VWDRY) and Eaton (ETN). But which of these two stocks presents investors with the better value opportunity right now?

HDLMY vs. ROAD: Which Stock Is the Better Value Option? — Positive
ROAD Zacks Investment Research — July 14, 2025Investors with an interest in Building Products - Miscellaneous stocks have likely encountered both Heidelberg Materials AG Unsponsored ADR (HDLMY) and Construction Partners (ROAD). But which of these two stocks presents investors with the better value opportunity right now?

MGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer Biomet — Neutral
MGRM GlobeNewsWire — July 14, 2025MONSEY, N.Y., July 14, 2025 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Monogram Technologies, Inc. (Nasdaq: MGRM) (“Monogram”) to Zimmer Biomet for an upfront payment of $4.04 per share in cash, and a non-tradeable contingent value right (CVR) entitling the holder to receive up to $12.37 per share in cash if certain product development, regulatory, and revenue milestones are achieved through 2030.

Gold, silver see routine profit-taking pressure — Neutral
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL SIL SILJ SIVR SLV SLVP UGL Kitco — July 14, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

FDA Rejects CAPR's Cell Therapy BLA for Genetic Disorder, Stock Tanks — Negative
CAPR Zacks Investment Research — July 14, 2025Capricor slumps 33% as the FDA rejects its BLA for DMD drug, deramiocel, citing lack of effectiveness data and CMC issues.

Autodesk signals it will no longer pursue PTC acquisition, shares rise — Positive
ADSK Proactive Investors — July 14, 2025Autodesk Inc (NASDAQ:ADSK) shares gained almost 6% on Monday after the company signalled it has dropped its pursuit of acquiring PTC Inc (NASDAQ:PTC), a fellow engineering software firm valued at about $23 billion. In a filing with the Securities and Exchange Commission (SEC), Autodesk said it will be focused on its strategic priorities, indicating there will be no deal with PTC without mentioning the Boston-based firm by name.

OXY Stock is Trading Above 50-Day SMA: Time to Buy, Hold or Sell? — Positive
OXY Zacks Investment Research — July 14, 2025OXY is trading above its 50-day SMA after a 22.5% rally, fueled by Permian strength and international assets.

Here's Why Silver ETFs Are Soaring to New Highs — Positive
SLV Zacks Investment Research — July 14, 2025SLV and SIVR surge as silver hits highs not seen since 2011, fueled by tariffs, supply strain and soaring industrial demand.

Sinclair Launches Sinclair Cares: Help Drive Out Cancer, Joins the American Cancer Society to Raise Awareness and Support Free Rides to Medical Treatment — Neutral
SBGI Business Wire — July 14, 2025BALTIMORE--(BUSINESS WIRE)--Sinclair today announced a collaboration with the American Cancer Society (ACS) to launch Sinclair Cares: Help Drive Out Cancer, a nationwide campaign dedicated to raising awareness about the transportation barriers people with cancer face in accessing lifesaving treatment. The campaign spotlights the American Cancer Society Road To Recovery® program, which provides free rides to treatment for those in need, while encouraging volunteerism and financial support. As pa.

Autodesk's Stock Climbs Following Report It's No Longer Looking to Buy PTC — Positive
ADSK Investopedia — July 14, 2025Autodesk (ADSK) shares surged Monday following a report the company is no longer looking to purchase rival design software maker PTC (PTC).

Cash Doubles, Losses Widen: Is BigBear.ai Stock Still Worth the Risk? — Negative
BBAI Zacks Investment Research — July 14, 2025BigBear.ai Holdings BBAI is navigating a mixed financial picture in early 2025, leaving investors to weigh short-term margin pressure against longer-term strategic flexibility. In its first-quarter 2025 report, the company posted a wider adjusted EBITDA loss of $7 million compared with a $1.6 million loss a year ago.

Coinbase Is the Real Trump Trade as Stock Set for Record Closing High — Positive
COIN Barrons — July 14, 2025The crypto exchange is on pace to finish with a market capitalization just under $100 billion.

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reddit, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RDDT — Neutral
RDDT GlobeNewsWire — July 14, 2025NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.

PayPal Holdings, Inc. is generating billions in free cash flow, expanding margins, and gaining enterprise traction — yet the market still prices it like a dying fintech. With 436 million active users, sticky merchant relationships, and platform-agnostic tech, PayPal's network moat is stronger than analysts give it credit for. New leadership is cutting costs, focusing on high-margin products, and quietly executing a turnaround that could catch Wall Street off guard in 2025.

Mark Zuckerberg says Meta is building a 5GW AI data center — Positive
META TechCrunch — July 14, 2025Meta is currently building out a data center, called Hyperion, which the company expects to supply its new AI lab with five gigawatts (GW) of computational power, CEO Mark Zuckerberg said in a Monday post on Threads.

Is Pagaya Stock's Low Valuation an Opportunity or a Value Trap? — Positive
PGY Zacks Investment Research — July 14, 2025At a glance, Pagaya Technologies PGY stock looks attractively priced in terms of its price/sales (P/S) ratio when compared with its peers. Value investors try to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts compared with fair value.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS — Neutral
HIMS GlobeNewsWire — July 14, 2025NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SRPT — Neutral
SRPT GlobeNewsWire — July 14, 2025NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or the “Company”) (NASDAQ: SRPT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
